Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMO Bills Differ On Labeling, But Agree On Pre-empting State Laws

This article was originally published in The Tan Sheet

Executive Summary

H.R. 1599 would create a structure for codifying GMOs in foods and supplements and make labeling voluntary, but opponents say it keeps consumers in the dark while pre-empting state laws. S. 809 and H.R. 1699, meanwhile, would require labeling for genetically engineered products.

You may also be interested in...



NPA’s Wish List For Cosmetics Bill Includes GMPs, ‘Natural’ Definition

In an interview with “The Rose Sheet,” Natural Products Association Executive Director and CEO Dan Fabricant discussed the trade group’s priorities in developing cosmetics legislation while acknowledging that advocates may face an uphill battle in the current Congress.

Supplement Self-Regulation Key To Preventing More Oversight – Heinrich

The supplement industry’s new ally in the Senate, Martin Heinrich, encourages industry to increase self-regulation of energy drinks to avoid opening DSHEA to amendments. He also says national GMO labeling legislation could spare industry from a patchwork of state laws.

Zing Patch, Nubrain Water, Stay Alert Gummy: Alternatives To Caffeine In Energy Booster Space

Thync Global’s Zing Energy neurostimulation patch and Tesla Nootropics’ Nubrain Brainstorm caffeine-free water are promoted as alternatives to caffeine and energy drinks. They join a market dominated by big brands but with competition growing from products that boost energy without caffeine and sugar.

Topics

UsernamePublicRestriction

Register

PL220371

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel